{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:02:42Z","timestamp":1745820162620},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,8]]},"DOI":"10.7759\/cureus.51856","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T13:25:13Z","timestamp":1704720313000},"source":"Crossref","is-referenced-by-count":1,"title":["Primary Bone Lymphoma Masquerading as Multiple Myeloma: Challenges in the Diagnostic Workup of Severe Hypercalcemia"],"prefix":"10.7759","author":[{"given":"Elise","family":"Kahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Nomani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra M","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar","family":"Asmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo E","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011, 117:5019-32. 10.1182\/blood-2011-01-293050","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton LM","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006, 107:265-76. 10.1182\/blood-2005-06-2508","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04749.x","article-title":"Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases","volume":"124","author":"M\u00f8ller MB","year":"2004","unstructured":"M\u00f8ller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases. Br J Haematol. 2004, 124:151-9. 10.1046\/j.1365-2141.2003.04749.x","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database","volume":"89","author":"Castillo JJ","year":"2014","unstructured":"Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. 2014, 89:310-4. 10.1002\/ajh.23638","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2006.00644.x","article-title":"The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement","volume":"76","author":"Campbell J","year":"2006","unstructured":"Campbell J, Seymour JF, Matthews J, Wolf M, Stone J, Juneja S. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Haematol. 2006, 76:473-80. 10.1111\/j.1600-0609.2006.00644.x","journal-title":"Eur J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.3419","article-title":"Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP","volume":"29","author":"Sehn LH","year":"2011","unstructured":"Sehn LH, Scott DW, Chhanabhai M, et al.. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2011, 29:1452-7. 10.1200\/JCO.2010.33.3419","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00106-5","article-title":"Localized primary malignant lymphoma of bone","volume":"37","author":"Dubey P","year":"1997","unstructured":"Dubey P, Ha C, Besa P, et al.. Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phy. 1997, 37:1087-93. 10.1016\/S0360-3016(97)00106-5","journal-title":"Int J Radiat Oncol Biol Phy"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000923","article-title":"Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-Cell lymphoma derived from centrocytes in the germinal center","volume":"41","author":"Li X","year":"2017","unstructured":"Li X, Xu-Monette ZY, Yi S, et al.. Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-Cell lymphoma derived from centrocytes in the germinal center. Am J Surg Pathol. 2017, 41:1309-21. 10.1097\/PAS.0000000000000923","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720958538","article-title":"Primary lymphoma of bone: a population-based study of 2558 patients","volume":"11","author":"Liu CX","year":"2020","unstructured":"Liu CX, Xu TQ, Xu L, Wang PP, Cao C, Gao GX, Zheng YH. Primary lymphoma of bone: a population-based study of 2558 patients. Ther Adv Hematol. 2020, 11:2040620720958538. 10.1177\/2040620720958538","journal-title":"Ther Adv Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24828","article-title":"Primary lymphoma of bone in adult patients","volume":"116","author":"Jawad MU","year":"2010","unstructured":"Jawad MU, Schneiderbauer MM, Min ES, Cheung MC, Koniaris LG, Scully SP. Primary lymphoma of bone in adult patients. Cancer. 2010, 116:871-9. 10.1002\/cncr.24828","journal-title":"Cancer"},{"key":"ref12","unstructured":"Diffuse Large B-Cell Lymphoma - Cancer Stat Facts. (2018). Accessed. December 20, 2023: https:\/\/seer.cancer.gov\/statfacts\/html\/dlbcl.html."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.09.021","article-title":"Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders","volume":"410","author":"Vermeersch P","year":"2009","unstructured":"Vermeersch P, Vercammen M, Holvoet A, Vande Broek I, Delforge M, Bossuyt X. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders. Clin Chim Acta. 2009, 410:54-8. 10.1016\/j.cca.2009.09.021","journal-title":"Clin Chim Acta"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar S","year":"2014","unstructured":"Rajkumar S, Dimopoulos M, Palumbo A, et al.. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:538-48. 10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu Y","year":"2019","unstructured":"Liu Y, Barta SK. Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2019, 94:604-16. 10.1002\/ajh.25460","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/sajc.sajc_90_17","article-title":"Bone marrow limited diffuse large B-cell lymphoma following prolonged immunosuppressive therapy with methotrexate and corticosteroids","volume":"7","author":"Dhiman P","year":"2018","unstructured":"Dhiman P, Anoop P, Patil CN. Bone marrow limited diffuse large B-cell lymphoma following prolonged immunosuppressive therapy with methotrexate and corticosteroids. South Asian J Cancer. 2018, 7:192. 10.4103\/sajc.sajc_90_17","journal-title":"South Asian J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.1994.9.2.113","article-title":"A case of coincident multiple myeloma and non-Hodgkin's lymphoma","volume":"9","author":"Lee GC","year":"1994","unstructured":"Lee GC, Hong JS, Lee KH, et al.. A case of coincident multiple myeloma and non-Hodgkin's lymphoma. Korean J Intern Med. 1994, 9:113-5. 10.3904\/kjim.1994.9.2.113","journal-title":"Korean J Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1676125","article-title":"Ewing's sarcoma and primary osseous lymphoma: spectrum of imaging appearances","volume":"23","author":"Weber MA","year":"2019","unstructured":"Weber MA, Papakonstantinou O, Nikodinovska VV, Vanhoenacker FM. Ewing's sarcoma and primary osseous lymphoma: spectrum of imaging appearances. Semin Musculoskelet Radiol. 2019, 23:36-57. 10.1055\/s-0038-1676125","journal-title":"Semin Musculoskelet Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2014.01.004","article-title":"Primary lymphoma of bone: a review","volume":"31","author":"Bhagavathi S","year":"2014","unstructured":"Bhagavathi S, Fu K. Primary lymphoma of bone: a review. Semin Diagn Pathol. 2014, 31:48-52. 10.1053\/j.semdp.2014.01.004","journal-title":"Semin Diagn Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/172786-primary-bone-lymphoma-masquerading-as-multiple-myeloma-challenges-in-the-diagnostic-workup-of-severe-hypercalcemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:41Z","timestamp":1707509681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/172786-primary-bone-lymphoma-masquerading-as-multiple-myeloma-challenges-in-the-diagnostic-workup-of-severe-hypercalcemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.51856","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}